ANRO - Alto Neuroscience, Inc.

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 6.08

Open

$ 5.80

Bid

$ 5.75 x 60

Ask

$ 6.30 x 250

Day's Range

$ 5.71 - $ 6.19

52 Week Range

$ 1.60 - $ 14.85

Volume

354,230

Average Volume

Market Cap

164.63M

Beta (5Y Monthly)

$ 1.91

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-13-2025	06-30-2025	10-Q
2	05-14-2025	03-31-2025	10-Q
3	03-20-2025	12-31-2024	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-13-2024	06-30-2024	10-Q
6	05-14-2024	03-31-2024	10-Q
7	03-21-2024	12-31-2023	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12 Health Care Stocks Moving In Friday's I...
10/03/2025 17:06:08

Alto Neuroscience Says FDA Grants Fast Tra...
10/03/2025 11:35:19

– ALTO-101, a novel PDE4 inhibitor, has demonstrated pro-cognitive effects in healthy volunteers –– Designation highlights the ...

12 Health Care Stocks Moving In Thursday's...
10/02/2025 21:06:15

this-electronic-arts-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-monday

This Electronic Arts Analyst Is No Longer ...
09/29/2025 11:52:38

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

this-vse-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday

This VSE Analyst Begins Coverage On A Bull...
09/29/2025 11:35:20

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

Chardan Capital Initiates Coverage On Alto...
09/29/2025 11:24:50

Chardan Capital analyst Rudy Li initiates coverage on Alto Neuroscience (NYSE: ANRO) with a Buy rating and announces Price T...

Alto Neuroscience Reports Replication Stud...
09/09/2025 11:16:01

Alto Neuroscience, Inc. ("Alto") (NYSE:ANRO) a clinical-stage biopharmaceutical company focused on the development of n...

HC Wainwright & Co. Reiterates Buy on Alto...
08/18/2025 17:11:11

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Alto Neuroscience (NYSE:ANRO) with a Buy and maintains $10 pr...

Alto Neuroscience Q2 EPS $(0.65) Misses $(...
08/13/2025 20:25:37

Alto Neuroscience (NYSE:ANRO) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0...

Alto Neuroscience Highlights Lancet Psychi...
06/30/2025 12:06:29

– Compelling PAX-D results guided Alto's acquisition of ALTO-207, designed to induce rapid antidepressant effects while mi...

HC Wainwright & Co. Reiterates Buy on Alto...
06/26/2025 16:16:35

HC Wainwright & Co. analyst Patrick Trucchio reiterates Alto Neuroscience (NYSE:ANRO) with a Buy and maintains $10 price...

Alto Neuroscience Identifies EEG Biomarker...
06/26/2025 11:37:24

Demonstrated target engagement and response prediction for ALTO-203 by theta/beta ratio, a commonly used EEG index of cortical ...

alto-neuroscience-adds-intriguing-depression-asset-via-over-100-million-deal

Alto Neuroscience Adds 'Intriguing' Depres...
06/03/2025 18:48:29

Alto Neuroscience acquires Chase's treatment-resistant depression drug portfolio for $1.75 million upfront; early data show...

Alto Buys Depression and Parkinson's Drug ...
06/03/2025 10:05:31

Alto Neuroscience, Inc. ("Alto") (NYSE:ANRO), a clinical-stage biopharmaceutical company focused on the development of ...

Wedbush Reiterates Neutral on Alto Neurosc...
05/15/2025 14:49:04

Wedbush analyst Laura Chico reiterates Alto Neuroscience (NYSE:ANRO) with a Neutral and maintains $4 price target.

Alto Neuroscience Q1 EPS $(0.56) Beats $(0...
05/14/2025 20:25:57

Alto Neuroscience (NYSE:ANRO) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.6...

Alto Neuroscience Announces Multiple Prese...
04/28/2025 12:16:10

– Identified and prospectively replicated an EEG-based biomarker for placebo response in MDD –– New data strengthen the mechani...

HC Wainwright & Co. Initiates Coverage On ...
04/07/2025 14:16:45

HC Wainwright & Co. analyst Patrick Trucchio initiates coverage on Alto Neuroscience (NYSE:ANRO) with a Buy rating and a...

Alto Neuroscience FY 2024 GAAP EPS $(2.50)...
03/20/2025 20:21:22

Alto Neuroscience (NYSE:ANRO) reported quarterly losses of $(2.50) per share which beat the analyst consensus estimate of $(2.5...

Alto Neuroscience Announces USPTO Granted ...
02/19/2025 13:12:26